ALR > Systemic Drug Delivery Event

Entity

Data Element

Definition

Format

Valid Values

Purpose and Use

Completion Requirement

Changes

Systemic Drug Delivery Event

Patient Chart Number

Patient identifier code that is unique within the healthcare facility.

CHAR 10
Alpha-numeric.

Consistent with CIHI NACRS definition and format.

Uniquely identifies a patient within an RCC.  Necessary to determine a case.  Foundational to most measures and indicators.

Mandatory

Systemic Drug Delivery Event

Visit Hospital Number

MOHLTC Master Number  for the healthcare facility where the cancer activity occurred (known by CIHI as Institution Numbers)

CHAR 4
Numeric

Same as CIHI’s Institution Number for NACRS or DAD submissions, but does not include CIHI’s provincial identifier digit. For current valid MOHLTC master numbers, see Appendix A.

Uniquely identifies the hospital organization to which this visit belong.

Mandatory

Systemic Drug Delivery Event

Submitting Hospital Number

The MOHLTC healthcare facility that submits activity to OH-CCO.

CHAR 4
Numeric

Valid MOHLTC facility numbers only.  Same 3-digit number that is used for MIS submissions.  An additional leading zero is acceptable.

For current valid MOHLTC facility numbers, see Appendix A.

Allows the hospital organization submitting the data to be distinguished from the hospital site where the service was delivered.

Mandatory

Systemic Drug Delivery Event

MIS Functional Centre

Subdivisions of an organization for the purpose of recording budgeted and actual revenues, expenses, and statistics pertaining to the function or activity being carried out. They are used to capture cost of labour, supplies, and equipment required to do specific functions.

CHAR 9

Valid MOHLTC Functional Centre Only

or current valid MOHLTC Functional centre numbers, see Appendix 1.1.

To be able to align OH-CCO activity data to MOHLTC OHRS reporting standards.

Systemic Drug Delivery Event

Visit Date

The date that the patient received systemic treatment. This can include:

•  Administration of parenteral chemotherapy in the cancer centre or hospital

•  Non-IV treatment (oral, intramuscular, subcutaneous), oral chemotherapy or hormonal agents.

• If the non-IV treatment was administered at the cancer centre or hospital, please report the date the non-IV treatment was administered as the visit date.

•  If the non-IV treatment was a take home medication, please report the date the prescription was ordered as the visit date 

YYYYMMDD 

Valid dates only.

Foundational to most measures and indicators – ALR, Wait Times, Funding. Used as a proxy for Consult date for Wait Times.  1^st  Consult date will be used for Wait Time .

Mandatory

Systemic Drug Delivery Event

Visit Time

Time of this activity.

HHMM 

0000 (midnight) to 2359, as per CIHI NACRS format.

Used for ALR to identify multiple visits in the same day.

Systemic Drug Delivery Event

CCO Regimen

A set of anti-cancer and supportive medications given during an active course of systemic chemotherapy that is named and defined in OH-CCO's Provincial Formulary Regimen List.

In addition to the Formulary Regimen list, a set of National Clinical Trial (NCT) numbers is available for entry when reporting a clinical trial.

CHAR 22

See Appendix 1.22 for a list of CCO regimen names.  In cases where the Regimen is not in the CCO regimen list, an RCC regimen name is acceptable.

If submitting a clinical trial regimen, an NCT number should be submitted as listed in Appendix 1.22

(CCO Regimen or NCT number can not be NULL)

Concordance with evidence-based practice guidelines, funding.

Systemic Drug Delivery Event

CCO Drug Code

OH-CCO hybrid of the First data Bank (FDB) drug number and OPIS generated drug numbers. Uniquely identifies the dug product in OPIS database.

CHAR 10

As per OPIS drug tables

Uniquely identifies a drug in OPIS.  Concordance with evidence-based practice guidelines, funding.

Conditionally Mandatory

Note: Mandatory if "DIN" is null

Systemic Drug Delivery Event

DIN

Health Canada Drug Identification Number.  Uniquely identifies the drug product by its manufacturer, name and strength of active ingredients, route of administration and pharmaceutical dosage form.

CHAR 8

Valid Health Canada DINs.

For clinical trial drugs not yet approved by Health Canada, use the value 9999999A for antineoplastic trial drugs or 9999999S for supportive trial drugs.

Uniquely identifies the drug product, as to its manufacturer, name and strength of active ingredients, route of administration and pharmaceutical dosage form. Used to identify drugs and to link to CCO drug codes for non-OPIS RCCs.

Conditionally Mandatory

Note: Mandatory if "CCO Drug Code" is null

Systemic Drug Delivery Event

Drug Origin Flag

Used to indicate whether the drug is from OPIS or First Data Bank (FDB).

CHAR 1

Y=Yes if FDB

N= No if not FDB/investigational created by OPIS.

Identifies if the drug is supplied by FDB or created as an investigational drug. Used to uniquely identify the drug given.

Conditionally Mandatory

Systemic Drug Delivery Event

Body Surface Area

Patient body surface area, calculated based on their height and weight using the MEDLOG formula,  in M2 (Square Meters).

REAL

Any positive real number.

Concordance with evidence-based practice guidelines.

Systemic Drug Delivery Event

Dose Administered

Actual drug dose administered during the patient's visit (total amount as opposed to metres squared).

REAL

Any non-negative real number.

If the dose is zero, OH-CCO assumes the patient arrived at the clinic but was not treated with this drug as planned.

Used to support cancer system planning and funding. 

Concordance with evidence-based guidelines and funding.

Systemic Drug Delivery Event

Measurement Unit

The international standard units of measurement for dosage. (e.g. mg=milligram)

CHAR 4

See Appendix 1.20 for CCO measurement unit codes.

Concordance with evidence-based guidelines and funding.

Systemic Drug Delivery Event

Route

The administration method for the drug (e.g. IV= intravenous).

CHAR 3

For current valid OPIS route codes and description, see Appendix 1.21.

Used to categorize drugs for analysis purposes.

Systemic Drug Delivery Event

Intent of Systemic Treatment

Intent of systemic treatment as determined by the oncologist at the time of booking the treatment visit.

CHAR 1

C = Curative, P = Palliative,
A = Adjuvant, or N = Neoadjuvant

Enter U for Unknown 

See Appendix 1.19 for definitions of each term.

Concordance with evidence-based guidelines and funding.

Systemic Drug Delivery Event

Line of Therapy

Identifies each line of therapy given to a patient for incurable disease (palliative intent). Refers to a regimen given to control disease.

Integer

1 through 99

To identify line of therapy in treating disease

Systemic Drug Delivery Event

Inpatient Flag

Identifies whether the patient is currently registered as an inpatient at this healthcare facility.

CHAR 1

Y=Yes for inpatient, N=No

Used to identify activity provided to inpatients. 

Systemic Drug Delivery Event

Arrived But Not Treated

Identifies those patients who arrive in a suite but are medically unable or unwilling to receive treatment.

CHAR 1

Y = Yes or N = No

Identifies those patients who arrive in a suite but are medically unable or unwilling to receive treatment.

Systemic Drug Delivery Event

CMIR Severity

Identifies level of Cancer Medication Infusion Reaction severity.

CHAR 1

blank-no reaction

0-no reaction

1-Mild transient reaction; infusion interruption not indicated; intervention not indicated

2-Therapy or infusion interruption indicated but responds promptly to symptomatic treatment (e.g., antihistamines, NSAIDS, narcotics, IV fluids); prophylactic medications indicated for <=24 hrs

3-Prolonged (e.g., not rapidly responsive to symptomatic medication and/or brief interruption of infusion); recurrence of symptoms following initial improvement; hospitalization indicated for clinical sequelae

4-Life-threatening consequences; urgent intervention indicated

5-Death

To determine level of severity for each reported Cancer Medication Infusion Reaction incidence

Optional for FY 2019/20.

Mandatory starting with FY 2020/21.

Systemic Drug Delivery Event

Registration Date

Date this patient was first registered at this RCC and/or hospital for this disease

YYYYMMDD 

Valid dates only.

Used as a surrogate for date of initial diagnosis when date of initial diagnosis in not available. Additional purpose: Used to derive disease sequence number for sites who do not submit the disease sequence number. Therefore used to link clinic visit activity to patient’s disease.

Mandatory

Systemic Drug Delivery Event

Disease Sequence Number

The numeric sequence assigned to a primary cancer for a patient at a specific healthcare facility.

INTEGER

1 through 99.

When combined with a patient identifier, disease sequence number uniquely defines a cancer case.

Disease Sequence Number must be either entered or left blank on ALL records in ALL entities from a submitting site, and that must remain consistent from month to month.

If left blank, OH-CCO will derive a value from the Registration Date.  If this is the case, the field must be unique amongst Diseases within the Patient.

Used in ALR, Ontario Cancer Registry, Wait Times, Planning, and funding.

Systemic Drug Delivery Event

HCP Number

Healthcare professional identifier code for the physician or non-physician who is most responsible for the patient or   This code is unique to the submitting healthcare facility.

CHAR 15

Numeric only as per CIHI NACRS format.

For physicians, this code has historically been the physician’s OHIP billing number in OPIS.

Uniquely identifies a healthcare professional (physician or non-physician) so patient activity can be linked to a  healthcare provider.

Mandatory

Systemic Drug Delivery Event

Patient Postal Code

Patient’s postal code of their home address on the date of this event.

CHAR 10

Canadian postal codes must be in the format ANANAN (no space), where A is a letter and N is a number. For US zip codes, use either NNNNN or NNNNN-NNNN. CIHI’s two-letter province/state codes are also acceptable if full code not known or for non-Canadian residence. See Appendix B. 

Used for generating prevalence rates by region, registry linking, Planning, Ontario Cancer Registry.

Mandatory